Focused Wealth Management, Inc - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 194 filers reported holding GW PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Focused Wealth Management, Inc ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2017$3,000
-75.0%
20
-88.1%
0.00%
-85.7%
Q4 2015$12,000
-20.0%
1680.0%0.01%
-30.0%
Q3 2015$15,000
-28.6%
1680.0%0.01%
-23.1%
Q2 2015$21,000
+40.0%
1680.0%0.01%
+44.4%
Q1 2015$15,000
+36.4%
1680.0%0.01%
+12.5%
Q4 2014$11,000
-21.4%
1680.0%0.01%
-27.3%
Q3 2014$14,0001680.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders